Schaff LR, Piotrowski AF, Pentsova E, Gavrilovic IT, et al. Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma. Neuro Oncol 2025;27:2107-2116.
PMID: 40269592